Moolec Science (NASDAQ:MLEC) Downgraded to “Sell” Rating by Wall Street Zen

Moolec Science (NASDAQ:MLEC) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Sunday.

Moolec Science Price Performance

MLEC stock opened at $7.27 on Friday. Moolec Science has a 1-year low of $3.08 and a 1-year high of $157.05. The company has a market capitalization of $5.28 million, a price-to-earnings ratio of -0.22 and a beta of -0.36. The business has a 50 day simple moving average of $9.55 and a two-hundred day simple moving average of $7.86.

Institutional Trading of Moolec Science

A hedge fund recently bought a new stake in Moolec Science stock. Citadel Advisors LLC bought a new position in shares of Moolec Science SA (NASDAQ:MLEC) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned about 0.90% of Moolec Science at the end of the most recent quarter. 0.07% of the stock is owned by hedge funds and other institutional investors.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.